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Abstract: Fluorescence immunoassays employing monoclonal antibodies directed against 
the explosive 2,4,6-trinitrotoluene (TNT) were conducted in a multi-channel 
microimmunosensor. The multi-channel microimmunosensor was prepared in poly (methyl 
methacrylate) (PMMA) via hot embossing from a brass molding tool. The multi-channeled 
microfluidic device was sol-gel coated to generate a siloxane surface that provided a 
scaffold for antibody immobilization. AlexaFluor-cadaverine-trinitrobenzene (AlexaFluor-
Cad-TNB) was used as the reporter molecule in a displacement immunoassay. The limit of 
detection was 1-10 ng/mL (ppb) with a linear dynamic range that covered three orders of 
magnitude. In addition, antibody crossreactivity was investigated using hexahydro-1,3,5-
triazine (RDX), HMX, 2,4-dinitrotoluene (DNT), 4-nitrotoluene (4-NT) and 2-amino-4,6-
DNT. 
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1. Introduction  
Characterization and remediation of military sites contaminated with energetic materials has 
continued to be an important topic in recent years. Two of the three major classes of energetic 
materials are nitroaromatics and nitramines [e.g., 2,4,6-trinitrotoluene (TNT) and hexahydro-1,3,5-
triazine (RDX)]. These materials are known to penetrate the soil and dissolve into the groundwater or 
seawater with the potential for endangering the marine environment [1]. TNT also has the capability of 
being absorbed through the skin in humans and other living species resulting in acute and/or chronic 
reactions [2]. Based on EPA evaluations TNT has been classified as a “possible human carcinogen”. 
These health risks to humans along with the toxic and mutagenic effects to all other life forms has 
generated a sense of urgency to develop new technologies that can detect, contain and remediate these 
toxic substances. With TNT toxic levels reported at 2.0 ng/mL by the Environmental Protection 
Agency (EPA) in both soil and groundwater [3], new methods and devices must have the capability of 
detecting explosive concentrations at trace levels, but also must be designed for field deployment to 
enable on-site analysis. Deployment of such novel devices will not only help to monitor the movement 
of these energetic materials as they migrate in underground plumes, but will significantly aid in the 
remediation efforts by reducing costs associated with sampling and analysis. 
Sensors to detect explosives have been designed and engineered in a number of formats [4-6]. Most 
prominent are the electrochemical sensors that employ square wave voltammetry. Wang and 
colleagues recently developed a flow through device for the detection of TNT. Using a carbon fiber 
working microelectrode employing a reduction process of TNT they were able to demonstrate 
detection at 100 ppb for environmental samples [7-9]. The development of a capillary electrophoresis 
microchip for TNT detection in non-aqueous media followed [10]. Combining a pre-concentration step 
(solid phase extraction matrix) with an electrophoresis microchip improved detection to sub parts-per-
billion levels. Trammell and colleagues also demonstrated that TNT could be detected using 
interdigitated array (IDAs) gold electrodes [11]. Using an amplified redox cycling method at the IDAs 
surface TNT could be detected at concentrations of 6 ng/mL (ppb) with a linear response from   
10-10,000 ng/mL. Although low ppb detection was achieved, the kinetics involved in the 
electrochemical transformations at the electrode surface was reported as a potential limiting factor.  
Technologies that use biomolecules to detect TNT have also been employed. Surface plasmon 
resonance (SPR) sensors are one of the many techniques that rely on changes in resonance angles 
when biomolecular interactions occur between an immobilized antigen and antibody [12,13]. Mizuta 
and colleagues demonstrated detection of TNT using a modified Au sensor surface immobilized with a 
TNT analog [14]. By incorporating an aromatic alkanedithiol and an oligo(ethylene glycol) linker they 
were able to achieve detection levels of 80 parts-per-trillion (ppt). Biosensors composed of fused-silica 
microcapillaries or resins have shown promise for the detection of TNT and RDX [15-20]. Antibodies 
specific for TNT or RDX immobilized on these surfaces have demonstrated recognition and specificity 
at the ppt to low ppb detection levels. In addition, immunoassays to detect TNT using fluorescent latex 
microspheres have been investigated [21,22]. Luminex
100 based fluid array immunoassays have 
demonstrated pg/mL detection levels for TNT in a multiplexed assay format. This assay system which 
employs a two laser based flow cytometry method has the potential for discriminating up to   




sensitivity, concerns arise regarding portability and fragility of sensor components when exposed to 
harsh environmental conditions. 
As biosensors and microfluidic devices evolve so to have the platforms upon which these sensing 
elements reside. In an effort to design more robust, less expensive sensing platforms researchers are 
increasingly employing thermoplastics such as poly(methyl methacrylate) (PMMA). PMMA is 
inexpensive and easily adaptable to thermoforming techniques. PMMA is amenable to a variety of 
surface modification chemistries (acid catalyzed, plasma oxidation, UV and aminolysis) for the 
immobilization of biomolecules by conversion of the terminal ester groups to functional moieties (e.g., 
carboxylic acids or primary amines). At first glance this process may seem trivial; however, 
researchers have discovered that bond strength and the elasticity of PMMA can be significantly 
influenced by the modification chemistry employed which may invariably impact the robustness of the 
microchip [23,24]. A capillary immunosensor to detect the explosive, RDX using PMMA as its 
backbone was demonstrated [25]. Using a micro-milling technique and standard sol-gel and 
immunosilane chemistry provided a method of producing a microchannel for covalent attachment of 
antibodies specific for RDX. Levels of detection were reported as low as 10 pg/mL. In addition, an 
immunosensor using inline integrated microfluidic mixer grooves was developed for the detection of 
TNT [26]. Chevrons and stripes layered in opposite directions on the top and bottom of the PMMA 
microchannel were the key components of the microfluidic mixer. These unique features created a 
near-turbulent flow within the microchannel which resulted in improved mixing of the biomolecules 
generating advection patterns for increased antibody-antigen interaction. Levels of detection for TNT 
were reported at 50 pg/mL. Most recently, a microfluidic device containing a series of parallel high 
aspect ratio microchannels was replicated into PMMA from a metal mold master [27]. This allowed 
processing large sample volumes in the microfluidic regime where picoliter samples volumes dominate 
high aspect ratio microstructures. This device was used to process mL scale volumes of fluid in a 
matter of minutes whereby circulating tumor cells were isolated from whole blood. This application 
clearly demonstrates the promise of microfluidic immunosensors in the future.    
This study outlines the fabrication of a multi-channeled PMMA microfluidic device that can be 
used as a substrate for the immobilization of monoclonal antibodies specific for the detection of TNT. 
Multiple microchannels (39 parallel; 25 mm channels) were hot-embossed into PMMA. The channels 
were coated with a sol-gel film to generate a siloxane surface for antibody immobilization. Using a 
displacement immunoassay format, monoclonal antibodies directed against TNT were covalently 
immobilized in the microchannels via a heterobifunctional crosslinker. AlexaFluor-cadaverine-
trinitrobenzene (AlexaFluor-Cad-TNB) which served as the fluorescence reporter molecule was 
allowed to bind in the antibody binding sites prior to TNT exposure forming the sensing complex. In 
the presence of TNT, the antibody would release the fluorescence reporter molecule which would be 
measured with a fluorescence detector downstream. The advantage of using this design and antibody 
immobilization protocol is an increase in the sensing surface area and the potential for high   




2. Results and Discussion  
The multi-channel PMMA microfluidic device (Figure 1) was prepared via hot-embossing and tri-
solvent annealing (see Experimental section). Microchannels were coated with a sol-gel film using a 
previously described protocol [25]. The sol gel film provided a means to covalently attach antibodies 
specific for TNT. After antibody immobilization, a fluorescent analog of TNT, AlexaFluor-Cad-TNB, 
was applied and allowed to bind to the immobilized antibody. Using a displacement immunoassay 
format, TNT was detected as low as 1 ng/mL.  
Figure 1. Multi-channel PMMA microfluidic device. (Left) The microfluidic device 
consisted of a hot-embossed 9 mm thick PMMA substrate that was tri-solvent bonded to a 
1.0 mm thick PMMA coverslip. The footprint of the microfluidic device is   
76 × 25 × 25 mm. The microfluidic device features flat-bottom 1.0 mm through holes at the 
inlet and outlet ports for fluid processing. (Right) Brightfield micrograph taken a   
2x magnification of the hot-embossed substrate used to assemble the microfluidic device. 
 
TNT dose response curves from three series of sequential TNT injections (low to high 
concentrations) were measured and plotted (Figure 2a). From the dose response curves two 
observations were noted. The first observation was the continual decrease in the fluorescence signal 
with each successive series of TNT injections. As observed in prior work depletion in fluorescence 
signal over time is a common observation when using the displacement immunoassay format [18,19]. 
Antibody affinity, flow rate and other factors have been shown to influence the rate of fluorophore 
depletion [16]; however, in this instance the fluorescence response was at least 3x signal-to-noise. The 
second observation was the nonlinearity at the highest TNT concentration applied to the microfluidic 
device. This likely demonstrates we have exceeded the linear dynamic range of the assay. In addition 
to different degrees of binding by the antibody, antibody binding sites could be inaccessible due to the 
antibody orientation making displacement of the fluorescence probe more difficult. Figure 2b displays 
fluorescence signal responses for TNT at low concentrations (1 ng/mL, 10 ng/mL and 25 ng/mL). 
After normalizing the data of the three series a linear range was observed between 1 ng/mL to   
250 ng/mL with an r
2 value of 0.989 (Figure 2c).  




Figure 2. (a) Dose response curves for TNT using a multi-channel PMMA microfluidic 
device. Series 1 (filled diamonds), Series 2 (open squares) and Series 3 (filled triangles). 
(b) Bar plot of dose responses for TNT at low concentrations seen in Figure 2a. Series 1 
(filled), Series 2 (open) and Series 3 (slanted). (c) Linear plot of normalized data from 
series 1-3 from TNT concentration 1-250 ng/mL (r







Further immunoassays were performed to test antibody specificity. Results showed that RDX, 
HMX and 4-nitrotoluene (4-NT) had minimal to no crossreactivity with the TNT antibody. Sensor 
response, as shown in Table 1, for the non-aromatic molecules (RDX and HMX) and 4-NT resulted  
in <3% crossreactivity. However, 2,4-DNT and 2-amino-4,6-DNT produced slightly higher 




14.4%, respectively. It is well known that antibody–antigen interactions can be influenced by 
conformation of the antigen. In this instance TNT has a nearly planar conformation with the nitro 
groups twisted out of the plane of the aromatic ring. This conformation is typical of nitroaromatic 
compounds. The non-aromatic molecules (RDX and HMX) (Figure 3) adopt very different 
conformations with the ring assuming a chair conformation [28] and the nitro groups in axial positions. 
It is not surprising that 2,4-DNT has the highest crossreactivity as its conformation is nearly identical 
to that of TNT while 2-amino-4,6-DNT has a lower crossreactivity possibly because of both the amino 
group and its effect on conformation (one of the nitro groups is in the plane of the aromatic ring).    
Figure 3. Conformation of explosives included in this study based on crystallographic 
studies (TNT [29], 2,4-DNT [30], 2-amino-DNT [31], 4-NT [32], RDX [33], and HMX [34]). 
 
Table 1. Percent crossreactivity of explosives to TNT antibody. Explosive samples applied 
in TNT immunoassay at a concentration of 100 ng/mL. All samples were applied in 
duplicate. Fluorescence peak areas were averaged and percent (%) crossreactivity 
recorded.  
Explosive   Concentratio
n (ng/mL) 
Fluorescenc




2,4,6-Trinitrotoluene (TNT)  100  2905284  - 
RDX  100  4077  1.4 
HMX   100  8015  2.7 
2,4- Dinitrotoluene (2,4-DNT)  100  723105  24.8 
4-Nitrotoluene  100  7255  2.5 
2-Amino-4,6-dinitrotoluene (2ADNT)  100  420318  14.4 
 
To simulate environmental samples, seawater was spiked with TNT and analyzed using the 




we observed that the solution became opaque and a white precipitate began to occur. Seawater which 
contains a number of components; chloride, sodium, sulfate, magnesium, calcium, potassium and 
bicarbonates can easily form insoluble calcium phosphates when combined with sodium phosphates. 
To prevent the precipitate from occurring conditions were optimized by reducing the phosphate to   
10 mM and the Tween 20 concentration to 0.01% for the desired system flow buffer of 90% seawater  
+10% flow buffer [10 mM Na Phosphate, pH7.4 + Tween 20 (0.01%)]. A transparent solution was 
achieved preventing any potential clogging of lines or system back pressure. TNT dose response 
curves from three series of sequential TNT injections (low to high concentrations) were measured and 
plotted (Figure 4). TNT dose response curves in seawater showed a similar trend to assays performed 
in PBS-Tween 20 (Figure 1) and in previously reported work [26]. A noticeable fluorescence plateau 
at the higher concentrations was observed.  
Figure 4. Dose response curves for TNT in seawater using multi-channel PMMA 
microfluidic device. TNT samples were prepared in 90% seawater: 10% flow buffer   
(10 mM Na-Phosphate, pH 7.4 + Tween 20 (0.01%). Series 1 (filled diamonds), Series 2 
(open squares) and Series 3 (filled triangles).  
 
3. Experimental Section  
3.1. Antibodies, Antigens and Reagents 
The monoclonal antibodies specific for TNT (mAb clone 30-1) was custom developed by Cell 
Essentials, Inc. - (Boston, MA, USA; http://www.cell-essentials.com/custom-monoclonalframesethtm) 
for NRL. 3-Mercaptopropyltrimethoxysilane, tetraethylorthosilicate (TEOS) and dimethylsulfoxide 
(DMSO) were obtained from Sigma-Aldrich-Fluka Corp. (Milwaukee, WI, USA).   
2,4,6-Trinitrotoluene (TNT), hexahydro-1,3,5-triazine (RDX), 1,3,5,7-tetranitro-1,3,5,7-tetrazocane 
(HMX), 2,4-dinitrotoluene (DNT), 4-nitrotoluene (4-NT) and 2-amino-4,6-DNT were purchased from 
Cerilliant, Inc. (Round Rock, TX, USA). N-succinimidyl-4-maleimidobutyrate (GMBS) and   




IL, USA). Seawater was obtained from Narragansett, Bay (RI, USA). AlexaFluor 647 cadaverine 
disodium salt was purchased from Invitrogen-Molecular Probes (Carlsbad, CA, USA). Purification of 
AlexaFluor-Cad-TNB was achieved using Shimadzu Prominence RP-HPLC chromatography system 
equipped with a Waters C18 semi-preparative column (μm Bondapak; 10 μm; 19 × 300 mm) (Milford, 
MA, USA) with a gradient between methanol/water/acetic acid (10/90/0.1%) and 
methanol/water/acetic acid (100/0/0.1%). Micro 90 was purchased from Fisher Scientific, Inc. 
(Pittsburgh, PA, USA). Methanol and other solvents were of HPLC grade quality grade or higher. 
Solvents were purchased from Mallinckrodt Baker, Inc. (Phillipsburg, NJ, USA) and Fisher   
Scientific, Inc.    
3.2. High Precision Micro-Milling 
A Haas Mini Mill (Oxnard, CA, USA) was used to fashion a brass molding tool out of a   
6 × 101 × 50 mm brass feedstock (McMaster-Carr, Robbinsville, NJ, USA) using a 3-axis milling 
process. All milling bits used were obtained from Bits and Bits Co. (Silverton, OR, USA). After 
mounting the feed stock to the table the surface was leveled by removing 0.5 mm of the material with a 
12 mm diameter dual flute end mill bit at 0.25 mm per layer. The microstructures were then machined 
into the plate to achieve a feature height of 0.5 mm with a combination of tapered and non-tapered flat 
end mill bits. The microstructures were created by removing 0.02 mm layers with each pass of the end 
mill bit in all subsequent cuts. The feed rate used on the x and y axes was 101 mm/min with the z-axis 
at 25 mm/min. In a final finishing step the features were profiled with a 0.12 mm diameter end mill bit. 
3.3. Hot Embossing 
The molding tool described above was used to replicate polymeric substrates via hot-embossing 
into poly (methyl methacrylate) (PMMA) (McMaster-Carr, Robbinsville, NJ, USA). A 101 × 101 mm 
brass plate was polished to a mirror-like finish and used in conjunction with an aluminum embossing 
chamber. The molding tool had four 6 mm diameter through holes that were used to align the 
embossing chamber and PMMA with the raised microarchitectures within the molding tool. With the 
PMMA facing up the mirrored finish of the brass plate was placed in contact with the PMMA. The 
embossing chamber was 6 mm thick and the PMMA feedstock was 9 mm thick which provided excess 
PMMA resulting in an improved mold cavity fill during the embossing stage. The entire apparatus was 
then situated in an embossing press (fabricated in-house) between two temperature programmable 
heating platens. Thermocouples were center mounted in the platens to monitor the temperature during 
embossing. The lower platen in the press had a fixed z-axis and the upper platen was pneumatically 
actuated and capable of applying 40–120 psi of downward force to the stationary platen. Without 
applied pneumatic pressure the heating platens were brought into conformal contact with the apparatus 
at room temperature, at which time a 60 psi force was applied. The temperatures of both the upper and 
lower platens were then programmed to achieve 170 °C. Once the final temperature was reached, the 
apparatus temperature was maintained for a period of 45 minutes. The apparatus was then passively 
cooled to 50 °C before the press was opened. The embossed substrates were removed from the 
molding tool by applying force to the through holes which were occupied by the alignment pegs and 




Industrial, Bellingham, WA, USA). Included within the microarchitecture were four additional 
alignment markers used to drill through holes (3 mm diameter) with a bench top mounted drill press 
(Ryobi, Tempe, AZ, USA). Fluidic conduits were also drilled for the influent and effluent (1 mm 
diameter) lines. 
3.4. Tri-solvent Annealing 
The embossed substrates were cleaned using a mild Micro 90 solution prepared by dissolving 5 mL 
in 1 L of de-ionized (DI) H2O followed by rinsing with copious amounts of reagent grade isopropyl 
alcohol. The substrates were placed in a Branson 2510 sonicator (Danbury, CT, USA) for 20 min. 
Coverslips that were 76 × 25 mm were milled from 1.5 mm thick PMMA feedstock using the Mini 
Mill. The coverslips were cleaned and sonicated in an analogous manner to that described above. A 
slight modification to a previously described tri-solvent annealing protocol [23] was implemented. 
Briefly, one of the coverslips was placed on a clean dry 101 × 101 × 3 mm tempered borosilicate plate 
and 10 drops of a solution containing 47.5% DMSO, 47.5% DI H2O, and 5% methanol were equally 
spaced on the coverslip using a Pasteur pipette. The leading edge of the embossed substrate was placed 
in contact with the leading edge of the coverslip. The embossed substrate was slowly lowered until 
conformal contact between both pieces was obtained. A second borosilicate plate was placed on top 
and the apparatus was clamped together with four 2 inch paper clamps (Acco Brands Inc. Lincolnshire 
IL, USA). The apparatus was placed in a temperature programmable oven (Agilent, Wilmington, DE, 
USA) and heated to 90 ºC at a rate of 20 °C/min. The final temperature was maintained for 35 min 
before the oven was cooled to 35 °C. The devices were tested for leaks by interfacing to an Applied 
Biosystems 400 reciprocating pump (Foster City, CA, USA). Three aliquots of 1 mL DI H2O were 
delivered to the device at 1, 2 and 3 mL/min. The effluent was captured in tared vessels and weighed. 
Devices with 95–105% recovery were deemed to have no leaks and used for assays. 
3.5. Immobilization of Antibody Specific for TNT  
Monoclonal antibodies specific for TNT were immobilized within the multi-channeled PMMA 
microfluidic device using a previously described protocol [25]. Briefly, a sol-gel solution, 
tetraethylorthosilicate (TEOS), was applied to the microfluidic device via a syringe pump at a flow 
rate of 100 μL/min and allowed to incubate for 2 min. The solution was then withdrawn from the 
microchannel at the same flow rate leaving a sol-gel coated PMMA surface. The TEOS coated PMMA 
surface was allowed to incubate in a humidified oven at 60 °C for a minimum of 5h. Afterwards, the 
microchannels were base cleaned with 1N NaOH, rinsed with 18 MΩ Milli-Q water, acid cleaned with 
5 M HCL and then treated with a 4% solution of 3-mercaptopropyltrimethoxysilane prepared in 
methanol for 1h at room temperature (RT). The silane-coated microchannels were rinsed with 
methanol and dried briefly. Next a solution of N-succinimidyl-4-maleimidobutyrate (GMBS; dissolved 
first with 2 drops of DMSO) (4 mM) in absolute ethanol was applied to the microchannels using a 1cc 
syringe and allowed to incubate for 1h at RT. Microchannels were subsequently rinsed with ethanol,  
18 MΩ Milli-Q water then dried briefly with an N2 stream. Antibodies specific for TNT (1 g/L in PBS,  
pH 7.4) were then infused in the microchannel and allowed to incubate at 4 °C overnight. Prior to 




blocked with a 1% solution of bovine serum albumin (BSA) in PBS, pH 7.4 for 2 h at RT. The 
functionalized microchannel device containing the immobilized antibody can be stored in the liquid 
blocking buffer (BSA in PBS, pH 7.4) indefinitely at 4 °C until saturation with the fluorescence 
analog. Once the microchannel device has been saturated with the fluorescence analog (dissolved in 
PBS, pH 7.4) it can remain in the liquid solution until commencement of immunoassay. This allows 
one to process and store many microchannel devices for future immunoassays. 
3.6. Synthesis and RP-HPLC Purification of AlexaFluor647-Cadaverine-TNB 
A fluorescent analog of TNT, AlexaFluor647-cadaverine-TNB (AlexaFluor-Cad-TNB), was 
synthesized and purified for use in the TNT immunoassay. AlexaFluor 647 cadaverine, disodium salt 
(0.1 μmole) was dissolved in 0.5 mL of borate buffer saline (BBS), pH 9.0. TNBSA (10.2 μmoles; 
100-fold excess) was added directly to the AlexaFluor solution and allowed to incubate with stirring 
for 1h at RT. Purification of AlexaFluor-Cad-TNB was achieved using Shimadzu Prominence   
RP-HPLC chromatography system equipped with a Waters C18 semi-preparative column (μm 
Bondapak; 10 μm; 19 × 300 mm) (Milford, MA, USA) with a gradient between methanol/water/acetic 
acid (10/90/0.1%) and methanol/water/acetic acid (100/0/0.1%). At a total flow rate of 4.0 mL/min 
efficient separation of the product from the initial reactant was achieved. UV/Vis detection of product 
was accomplished at 650 nm. The product, AlexaFluor-Cad-TNB, eluted at 30.7 min compared to the 
AlexaFluor 647 cadaverine which eluted at 25.0 min. The final product was dried down into amber 
vials and store at –20 °C until further use.  
3.7. Displacement Immunoassay for TNT 
Prior to the assay, the anti-TNT PMMA microfluidic device was filled with a 30 μM solution of the 
AlexaFluor-Cad-TNB dye conjugate (dissolved in PBS, pH 7.4) to saturate the antibody binding sites. 
Antigen binding was allowed to occur for 24 h at 4 °C. The following day excess fluorophore was 
removed from the microchannel using a syringe pump. The multi-channel microfluidic device was 
connected in-line with a Rheodyne three-way-valve HPLC injection loop (100 μL) to complete the 
system. Continuous fluid and sample flow throughout the system was achieved using an Applied 
Biosystems 400 reciprocating pump at a flow rate of 100 μL per min. Fluorescence detection was 
obtained with a Model FP2020-Plus Intelligent Spectrofluorometer purchased from Jasco, Inc. (Easton, 
MD) equipped with a 16 μL flow cell. Excitation and emission settings for the AlexaFluor-cad-TNB 
analog were set at 632 nm and 665 nm, respectively.  
A displacement immunoassay was performed using the anti-TNT coated multi-channeled PMMA 
microfluidic device. TNT samples (concentrations from 0 ng/mL to 500 ng/mL) were prepared in 
system flow buffer (PBS, pH 7.4 + Tween 20 (0.01%) and injected into the flow stream through the 
HPLC injection loop. Once the TNT sample reaches the antibody binding site, the TNT will displace 
the fluorescence analog from the antibody pocket producing an increase in the fluorescence signal over 
background. Three series of TNT injections were performed with a triple rinse of the injection loop 
with system flow buffer between each series to minimize cross contamination. A typical immunoassay 
involving 3 series of TNT injections requires approximately 1.5–2.0 hours. This is based on 7-8 TNT 




for buffer rinses between each series. Each injection is 100 μL and takes approximately 5–7 minutes 
from the initial injection to the peak summit then back to baseline. Total liquid volume per 
immunoassay can be between 9.0–12.0 mL. Using the displacement immunoassay format under 
continuous flow allows one the capability of increasing the flow rate, analyzing more samples and 
decreasing the total immunoassay time. Total fluorescence peak area for each concentration was 
integrated using Borwin Analytical Software that was purchased from Jasco, Inc. (Easton, MD, USA). 
Fluorescence dose response curves were recorded for each TNT concentration and plotted.  
3.8. Antibody Specificity Immunoassay 
To validate specificity of the TNT immunoassay, other explosives were applied to the anti-TNT 
multi-channel PMMA microfluidic device. Explosives with structures similar to TNT (e.g.,   
2,4-dinitrotoluene (DNT), 4-nitrotoluene (4-NT) and 2-amino-4,6-DNT) and explosives dissimilar in 
structure to TNT (e.g., RDX and HMX) were applied. Duplicate injections of each compound at a 
concentration of 100 ng/mL were applied to the sensor. Fluorescence signal responses were measured 
and recorded.  
3.9. TNT Immunoassay in Seawater 
In developing the TNT immunoassay for use in seawater a change in the flow buffer composition 
was required. Initial assays were performed using a system flow buffer that consisted of PBS + Tween 
20 (0.01%). For the seawater assay TNT samples (concentrations from 0 ng/mL to 500 ng/mL) were 
prepared in the new system flow buffer composed of 90% seawater + 10% flow buffer (10 mM Na 
Phosphate, pH7.4 + Tween 20 (0.01%) and injected into the flow stream through the HPLC injection 
loop. This was performed to prevent a white precipitate from forming in the solution. Three series of 
TNT injections were performed. Fluorescence dose response curves were recorded for each TNT 
concentration and plotted.  
4. Conclusions  
The development of sensors to detect trace levels of explosives requires improvements in all aspects 
of the sensors’ components. Of utmost importance is immunoassay sensitivity, but key factors that 
must be addressed include instrument durability, reagent costs and sensor performance with complex 
samples containing multiple interferents. We have reported a fabrication method using PMMA for the 
design of a multi-channeled immunosensor to detect TNT. This method employs a hot embossing 
technique that produces microarchitectures/microchannels where antibodies specific for TNT can be 
immobilized. Using a fluorescence analog of TNT (AlexaFluor647-cadaverine-TNB) as a means of 
detection and the multi-channeled PMMA sensor immobilized with the TNT antibody, we were able to 
achieve detection levels for TNT at 1.0 ng/mL. Immunoassays conducted in seawater also provided an 
indication of immunoassay performance in an environmental sample. Fluorescence dose responses and 
detection levels were similar to those recorded in standard buffer. Crossreactivity studies showed 
antibody specificity for TNT compared to RDX and HMX. However, some compounds similar in 




DNT, which are breakdown products of TNT, and can serve as a good environmental indicator of TNT 
contamination. Combining the design of the modified PMMA multi-channeled device and the 
specificity of a TNT antibody provides an inexpensive, robust sensor with the potential for high 
throughput real-time analysis.  
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